A Study of LY3023414 and Necitumumab in Squamous Lung Cancer
Status:
Terminated
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and activity of the study drug known
as LY3023414 in combination with necitumumab in participants with metastatic squamous
non-small cell lung cancer (NSCLC).